- Home
- MTLS vs LAB Comparison
MTLS vs LAB Comparison
Compare MTLS & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- LAB
- Stock Information
- Founded
- MTLS 1990
- LAB 1999
- Country
- MTLS Belgium
- LAB United States
- Employees
- MTLS N/A
- LAB N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- MTLS Technology
- LAB Industrials
- Exchange
- MTLS Nasdaq
- LAB Nasdaq
- Market Cap
- MTLS 316.0M
- LAB 372.1M
- IPO Year
- MTLS 2014
- LAB 2011
- Fundamental
- Price
- MTLS $5.77
- LAB $1.39
- Analyst Decision
- MTLS
- LAB Buy
- Analyst Count
- MTLS 0
- LAB 2
- Target Price
- MTLS N/A
- LAB $2.50
- AVG Volume (30 Days)
- MTLS 80.4K
- LAB 2.6M
- Earning Date
- MTLS 07-30-2025
- LAB 07-30-2025
- Dividend Yield
- MTLS N/A
- LAB N/A
- EPS Growth
- MTLS 43.31
- LAB N/A
- EPS
- MTLS 0.17
- LAB N/A
- Revenue
- MTLS $291,295,936.00
- LAB $169,687,000.00
- Revenue This Year
- MTLS $6.42
- LAB N/A
- Revenue Next Year
- MTLS $8.33
- LAB $12.18
- P/E Ratio
- MTLS $32.51
- LAB N/A
- Revenue Growth
- MTLS 6.16
- LAB 33.86
- 52 Week Low
- MTLS $3.93
- LAB $0.92
- 52 Week High
- MTLS $9.69
- LAB $2.41
- Technical
- Relative Strength Index (RSI)
- MTLS 56.86
- LAB 60.31
- Support Level
- MTLS $5.54
- LAB $1.27
- Resistance Level
- MTLS $5.85
- LAB $1.31
- Average True Range (ATR)
- MTLS 0.17
- LAB 0.11
- MACD
- MTLS 0.00
- LAB 0.01
- Stochastic Oscillator
- MTLS 78.33
- LAB 50.89
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.